TGF‑β/Smad3 pathway enhances the cardio‑protection of S1R/SIPR1 in in vitro ischemia‑reperfusion myocardial cell model

Yang,Tingfang; Zhang,Xianfeng; Ma,Cuimei; Chen,Yan

doi:10.3892/etm.2018.6192

July-2018 Volume 16 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-2018 Volume 16 Issue 1

Full Size Image

Article Open Access

TGF‑β/Smad3 pathway enhances the cardio‑protection of S1R/SIPR1 in in vitro ischemia‑reperfusion myocardial cell model

Authors:
- Tingfang Yang
- Xianfeng Zhang
- Cuimei Ma
- Yan Chen
View Affiliations / Copyright

Affiliations: Department of Pediatrics, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China, Department of Psychiatry, Jining Mental Health Hospital/Daizhuang Hospital of Shandong, Jining, Shandong 272051, P.R. China, Department of Pediatrics, Affiliated Hospital of Jining Medical University, Jining, Shandong 272000, P.R. China

Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Pages: 178-184
|
Published online on: May 18, 2018

https://doi.org/10.3892/etm.2018.6192
Expand metrics +

Abstract

Ischemia-reperfusion (IR) injury is usually associated with a high risk of cardiomyocyte death in patients with acute myocardial infarction. Sphingosine 1‑phosphate (S1P) and transforming growth factor (TGF)‑β are thought to be involved in the protection of cardiomyocyte and heart function following IR‑induced injury. However, the possible association of S1P and S1P receptor 1 (S1PR1) with the TGF‑β/Smad3 pathway as the potential protective mechanism has remained to be investigated. In the present study, an in vitro ischemia/reperfusion injury model was established and evaluated by analysis of apoptosis, lactate dehydrogenase (LDH) release and caspase3 activity. The mRNA and protein levels of S1PR1, TGF‑β and Smad3 after treatment with 1 µM S1P alone or combined with 0.4 µM W146 (a specific S1PR1 antagonist) were assessed. The mRNA expression of five S1PRs (S1PR1‑5) and the protein levels of S1PR1 were also assayed following treatment with 1 ng/ml TGF‑β for 0, 4 or 24 h. The mRNA expression of S1PR1 and the levels of S1P were further assessed following exposure to 10 µM SB4 (TGFβR1 inhibitor) plus 1 ng/ml TGF‑β and 2 µM SIS3 (Smad3 inhibitor) plus 1 ng/ml TGF‑β. The results indicated that apoptosis, LDH release and caspase3 activity were all increased in the established IR model. Exogenous S1P increased the mRNA and protein levels of S1PR1, TGF‑β and Smad3, which was abolished by addition of W146. Extraneous TGF‑β resulted in the stimulation of several S1PRs, most prominently of S1PR1, while supplementation with SB4 and SIS3 offset the stimulation by TGF‑β. These results suggested that the TGF‑β/Smad3 pathway was closely associated with S1P/S1PR1 in the protection of myocardial cells from IR injury.

View Figures

View References

1	Hausenloy DJ and Yellon DM: Myocardial ischemia-reperfusion injury: A neglected therapeutic target. J Clin Invest. 123:92–100. 2013. View Article : Google Scholar : PubMed/NCBI
2	Braunwald E and Kloner RA: Myocardial reperfusion: A double-edged sword? J Clin Invest. 76:1713–1719. 1985. View Article : Google Scholar : PubMed/NCBI
3	Piper HM, Garcia-Dorado D and Ovize M: A fresh look at reperfusion injury. Cardiovasc Res. 38:291–300. 1998. View Article : Google Scholar : PubMed/NCBI
4	Yellon DM and Hausenloy DJ: Myocardial reperfusion injury. N Engl J Med. 357:1121–1135. 2007. View Article : Google Scholar : PubMed/NCBI
5	Hearse DJ and Tosaki A: Free radicals and reperfusion-induced arrhythmias: Protection by spin trap agent PBN in the rat heart. Circ Res. 60:375–383. 1987. View Article : Google Scholar : PubMed/NCBI
6	Kloner RA, Bolli R, Marban E, Reinlib L and Braunwald E: Medical and cellular implications of stunning, hibernation, and preconditioning: An NHLBI workshop. Circulation. 97:1848–1867. 1998. View Article : Google Scholar : PubMed/NCBI
7	Krug A, Du Mesnil de Rochemont and Korb G: Blood supply of the myocardium after temporary coronary occlusion. Circ Res. 19:57–62. 1966. View Article : Google Scholar : PubMed/NCBI
8	Rosen H, Sanna Germana M, Gonzalez-Cabrera PJ and Roberts E: The organization of the sphingosine 1-phosphate signaling system. Curr Top Microbiol Immunol. 378:1–21. 2014.PubMed/NCBI
9	Ishii I, Fukushima N, Ye X and Chun J: Lysophospholipid receptors: Signaling and biology. Annu Rev Biochem. 73:321–354. 2004. View Article : Google Scholar : PubMed/NCBI
10	Im DS, Heise CE, Ancellin N, O'Dowd BF, Shei GJ, Heavens RP, Rigby MR, Hla T, Mandala S, McAllister G, et al: Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. J Biol Chem. 275:14281–14286. 2000. View Article : Google Scholar : PubMed/NCBI
11	Gräler MH, Grosse R, Kusch A, Kremmer E, Gudermann T and Lipp M: The sphingosine 1-phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13. J Cell Biochem. 89:507–519. 2003. View Article : Google Scholar : PubMed/NCBI
12	Knapp M: Cardioprotective role of sphingosine-1-phosphate. J Physiol Pharmacol. 62:601–607. 2011.PubMed/NCBI
13	Theilmeier G, Schmidt C, Herrmann J, Keul P, Schäfers M, Herrgott I, Mersmann J, Larmann J, Hermann S, Stypmann J, et al: High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation. 114:1403–1409. 2006. View Article : Google Scholar : PubMed/NCBI
14	Jin ZQ, Goetzl EJ and Karliner JS: Sphingosine kinase activation mediates ischemic preconditioning in murine heart. Circulation. 110:1980–1989. 2004. View Article : Google Scholar : PubMed/NCBI
15	Jin ZQ, Zhou HZ, Zhu P, Honbo N, Mochly-Rosen D, Messing RO, Goetzl EJ, Karliner JS and Gray MO: Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts. Am J Physiol Heart Circ Physiol. 282:H1970–H1977. 2002. View Article : Google Scholar : PubMed/NCBI
16	Karliner JS, Honbo N, Summers K, Gray MO and Goetzl EJ: The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J Mol Cell Cardiol. 33:1713–1717. 2001. View Article : Google Scholar : PubMed/NCBI
17	Robert P, Tsui P, Laville MP, Livi GP, Sarau HM, Bril A and Berrebi-Bertrand I: EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes. J Mol Cell Cardiol. 33:1589–1606. 2001. View Article : Google Scholar : PubMed/NCBI
18	Zhang J, Honbo N, Goetzl EJ, Chatterjee K, Karliner JS and Gray MO: Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. Am J Physiol Heart Circ Physiol. 293:H3150–H3158. 2007. View Article : Google Scholar : PubMed/NCBI
19	Toledo-Pereyra LH, Toledo AH, Walsh J and Lopez-Neblina F: Molecular signaling pathways in ischemia/reperfusion. Exp Clin Transplant. 2:174–177. 2004.PubMed/NCBI
20	Truty MJ and Urrutia R: Basics of TGF-beta and pancreatic cancer. Pancreatology. 7:423–435. 2007. View Article : Google Scholar : PubMed/NCBI
21	Chen H, Li D, Saldeen T and Mehta JL: TGF-β1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1. Am J Physiol Heart Circ Physiol. 284:H1612–H1617. 2003. View Article : Google Scholar : PubMed/NCBI
22	Feng XH and Derynck R: Specificity and versatility in TGF-β signaling through Smads. Annu Rev Cell Dev Biol. 21:659–693. 2005. View Article : Google Scholar : PubMed/NCBI
23	Massagué J, Seoane J and Wotton D: Smad transcription factors. Genes Dev. 19:2783–2810. 2005. View Article : Google Scholar : PubMed/NCBI
24	Vivar R, Humeres C, Ayala P, Olmedo I, Catalán M, García L, Lavandero S and Díaz-Araya G: TGF-β1 prevents simulated ischemia/reperfusion-induced cardiac fibroblast apoptosis by activation of both canonical and non-canonical signaling pathways. Biochim Biophys Acta. 1832:754–762. 2013. View Article : Google Scholar : PubMed/NCBI
25	Rutter WJ, Pictet RL and Morris PW: Toward molecular mechanisms of developmental processes. Annu Rev Biochem. 42:601–646. 1973. View Article : Google Scholar : PubMed/NCBI
26	Chen Z, Qi Y and Gao C: Cardiac myocyte-protective effect of microRNA-22 during ischemia and reperfusion through disrupting the caveolin-3/eNOS signaling. Int J Clin Exp Pathol. 8:4614–4626. 2015.PubMed/NCBI
27	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
28	Zhao J, Liu J, Lee JF, Zhang W, Kandouz M, VanHecke GC, Chen S, Ahn YH, Lonardo F and Lee MJ: TGF-β/SMAD3 pathway stimulates Sphingosine-1 phosphate receptor 3 Expression: IMPLICATION OF SPHINGOSINE-1 PHOSPHATE RECEPTOR 3 IN LUNG ADENOCARCINOMA PROGRESSION. J Biol Chem. 291:27343–27353. 2016. View Article : Google Scholar : PubMed/NCBI
29	Ham A, Kim M, Kim JY, Brown KM, Fruttiger M, D'Agati VD and Lee HT: Selective deletion of the endothelial sphingosine-1-phosphate 1 receptor exacerbates kidney ischemia-reperfusion injury. Kidney Int. 85:807–823. 2014. View Article : Google Scholar : PubMed/NCBI
30	Lefer AM, Ma XL, Weyrich AS and Scalia R: Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion. Proc Natl Acad Sci USA. 90:1018–1022. 1993. View Article : Google Scholar : PubMed/NCBI
31	Lefer AM, Tsao P, Aoki N and Palladino MA Jr: Mediation of cardioprotection by transforming growth factor-beta. Science. 249:61–64. 1990. View Article : Google Scholar : PubMed/NCBI
32	Mehta JL, Yang BC, Strates BS and Mehta P: Role of TGF-beta1 in platelet-mediated cardioprotection during ischemia-reperfusion in isolated rat hearts. Growth Factors. 16:179–190. 1999. View Article : Google Scholar : PubMed/NCBI
33	Moses HL, Yang EY and Pietenpol JA: TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights. Cell. 63:245–247. 1990. View Article : Google Scholar : PubMed/NCBI
34	Tsukada YT, Sanna MG, Rosen H and Gottlieb RA: S1P1-selective agonist SEW2871 exacerbates reperfusion arrhythmias. J Cardiovasc Pharmacol. 50:660–669. 2007. View Article : Google Scholar : PubMed/NCBI
35	Means CK and Brown JH: Sphingosine-1-phosphate receptor signalling in the heart. Cardiovasc Res. 82:193–200. 2009. View Article : Google Scholar : PubMed/NCBI
36	Forrest M, Sun SY, Hajdu R, Bergstrom J, Card D, Doherty G, Hale J, Keohane C, Meyers C, Milligan J, et al: Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes. J Pharmacol Exp Ther. 309:758–768. 2004. View Article : Google Scholar : PubMed/NCBI
37	Mazurais D, Robert P, Gout B, Berrebi-Bertrand I, Laville MP and Calmels T: Cell type-specific localization of human cardiac S1P receptors. J Histochem Cytochem. 50:661–670. 2002. View Article : Google Scholar : PubMed/NCBI
38	Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, Hobson JP, Rosenfeldt HM, Nava VE, Chae SS, Lee MJ, et al: Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest. 106:951–961. 2000. View Article : Google Scholar : PubMed/NCBI
39	Nakajima N, Cavalli AL, Biral D, Glembotski CC, McDonough PM, Ho PD, Betto R, Sandona D, Palade PT, Dettbarn CA, et al: Expression and characterization of Edg-1 receptors in rat cardiomyocytes: Calcium deregulation in response to sphingosine 1-phosphate. Eur J Biochem. 267:5679–5686. 2000. View Article : Google Scholar : PubMed/NCBI
40	Zhang G, Contos JJ, Weiner JA, Fukushima N and Chun J: Comparative analysis of three murine G-protein coupled receptors activated by sphingosine-1-phosphate. Gene. 227:89–99. 1999. View Article : Google Scholar : PubMed/NCBI
41	Liu R, Das B, Xiao W, Li Z, Li H, Lee K and He JC: A Novel Inhibitor of Homeodomain Interacting protein Kinase 2 mitigates kidney fibrosis through inhibition of the TGF-β1/Smad3 pathway. J Am Soc Nephrol. 28:2133–2143. 2017. View Article : Google Scholar : PubMed/NCBI
42	Yan YM, Ai J, Shi YN, Zuo ZL, Hou B, Luo J and Cheng YX: (+/−)-Aspongamide A, an N-acetyldopamine trimer isolated from the insect Aspongopus chinensis, is an inhibitor of p-Smad3. Org Lett. 16:532–535. 2014. View Article : Google Scholar : PubMed/NCBI
43	Kiyono K, Suzuki HI, Matsuyama H, Morishita Y, Komuro A, Kano MR, Sugimoto K and Miyazono K: Autophagy is activated by TGF-β and potentiates TGF-β-mediated growth inhibition in human hepatocellular carcinoma cells. Cancer Res. 69:8844–8852. 2009. View Article : Google Scholar : PubMed/NCBI